MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Mar 13, 2017
Insider Transaction Report
Form 4
PORTER MICHAEL E
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-03-10−60,000→ 0 totalExercise: $2.69Exp: 2020-12-08→ Common Stock (60,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-03-10−25,000→ 0 totalExercise: $2.69Exp: 2020-10-14→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2017-03-10$2.69/sh+85,000$228,650→ 839,448 total
Footnotes (1)
- [F1]This option is fully vested.